Inventor · disambiguated record
Rose Yen
Also filed as: YEN ROSE
49 granted patents·7 pending applications·181 citations·filing 2010–2024
98Inventor score
Files withRIGEL PHARMACEUTICALS INC39THERAVANCE RESPIRATORY CO LLC9HUGHES ADAM D2CHEN YAN1HUGHES ADAM1
Top patents by PatentIndex Score
56 records- 0196US10590121B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·10 cites·37 claims
- 0295US9982000B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·16 cites·14 claims
- 0395US8324200B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Dec 4, 2012·23 cites·46 claims
- 0492US9067925B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Jun 30, 2015·11 cites·10 claims
- 0591US9682957B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Jun 20, 2017·5 cites·2 claims
- 0691US9572802B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Feb 21, 2017·5 cites·30 claims
- 0791US9000173B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2014·Granted Apr 7, 2015·7 cites·5 claims
- 0891US8816088B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE INC·Filed 2013·Granted Aug 26, 2014·7 cites·1 claims
- 0991US8138345B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM·Filed 2010·Granted Mar 20, 2012·13 cites·3 claims
- 1090US10774076B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Sep 15, 2020·3 cites·21 claims
- 1190US10208074B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·5 cites·11 claims
- 1290US9975875B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted May 22, 2018·4 cites·3 claims
- 1390US8551978B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM D·Filed 2012·Granted Oct 8, 2013·7 cites·6 claims
- 1489US10208075B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·4 cites·17 claims
- 1589US9771350B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted Sep 26, 2017·4 cites·2 claims
- 1689US8343954B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·8 cites·7 claims
- 1789US2025326778A1Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1888US11530194B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·24 claims
- 1988US11492349B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 8, 2022·1 cites·21 claims
- 2088US9611260B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Apr 4, 2017·4 cites·14 claims
- 2188US9566278B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·6 cites·21 claims
- 2287US9084795B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·4 cites·19 claims
- 2386US11299486B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·1 cites·11 claims
- 2486US10065946B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Sep 4, 2018·4 cites·24 claims
- 2585US11787810B2Diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Oct 17, 2023·2 cites·13 claims
- 2685US9321763B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Apr 26, 2016·6 cites·64 claims
- 2784US10479783B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Nov 19, 2019·2 cites·6 claims
- 2883US11059814B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jul 13, 2021·1 cites·15 claims
- 2983US10947216B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·1 cites·28 claims
- 3083US10941140B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·2 cites·26 claims
- 3183US9920041B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Mar 20, 2018·2 cites·12 claims
- 3283US9682976B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·3 cites·55 claims
- 3383US9169249B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Oct 27, 2015·4 cites·17 claims
- 3482US11993594B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2022·Granted May 28, 2024·0 cites·17 claims
- 3582US11939317B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 3681US10138220B1Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Nov 27, 2018·1 cites·26 claims
- 3780US2022289776A1Pyrazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3880US2022024907A1Compositions and methods for inhibition of the jak pathwayRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3979US12043620B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Jul 23, 2024·0 cites·10 claims
- 4078US10414753B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 17, 2019·1 cites·29 claims
- 4178US10370367B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·1 cites·21 claims
- 4277US11174251B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Nov 16, 2021·0 cites·17 claims
- 4376US10710983B22,4-diamino-pyrimidine compounds and method for making and using the compoundsCHEN YAN·Filed 2017·Granted Jul 14, 2020·1 cites·28 claims
- 4476US2021024493A1Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist ActivityTHERAVANCE RESPIRATORY CO LLC·Filed 2020·Application pending·0 cites
- 4575USRE47396ECompositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted May 21, 2019·1 cites·10 claims
- 4674US10836744B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2020·Granted Nov 17, 2020·0 cites·22 claims
- 4774US10590107B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2019·Granted Mar 17, 2020·0 cites·26 claims
- 4874US2023095835A12,4-diamino-pyrimidine compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4972US10358433B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Jul 23, 2019·0 cites·26 claims
- 5070US11524955B22,4-diamino-pyrimidine compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Dec 13, 2022·0 cites·18 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →